Print | Email Page

Procter & Gamble acquires consumer health business of Merck KGaA

November 2018

Jones Day advised The Procter & Gamble Company (“P&G”) in its €3.4 billion ($4.2 billion) acquisition of the worldwide consumer health business of Merck KGaA. The consumer health business acquired is active across 44 countries and includes such strategic brands as Neurobion, Femibion, Nasivin, Bion3, and Seven Seas.

For additional information about this matter, please contact: Andrew M. Levine

Client(s): Procter & Gamble Company, The